Trials / Recruiting
RecruitingNCT05185245
Liver Transplantation for Non-Resectable Colorectal Liver Metastasis
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna · Academic / Other
- Sex
- All
- Age
- 18 Years – 73 Years
- Healthy volunteers
- Not accepted
Summary
The study aims to evaluate the efficacy of liver transplantation in the context of non-resectable colorectal liver metastasis. The primary endpoint is the overall survival in this group of patients while the secondary endpoint is the disease-free survival. Patients included in this protocol will be evaluated either for whole or partial liver transplantation from deceased or living donors. Type of different transplantations proposed are as follows: 1. Whole liver graft or partial liver (split) from a deceased donor 2. Partial liver graft retrieved from a deceased donor and orthotopically implanted after having performed a left hepatectomy in the recipient. 3. Partial liver graft retrieved from a deceased donor and heterotopically implanted if total hepatectomy can not be performed. 4. Partial liver graft retrieved from a living donor and orthotopically implanted after having performed total hepatectomy. 5. Partial liver graft retrieved from a living donor and orthotopically implanted after having after having performed a left hepatectomy in the recipient. 6. Partial liver graft retrieved from a living donor and heterotopically implanted if total hepatectomy can not be performed. In cases 2-3-5-6 total hepatectomy of native liver can be secondarily performed after having achieved a proper graft hypertrophy in order to avoid a small for size syndrome
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Liver Transplantation | Liver Transplantation for Non-Resectable Colorectal Liver Metastasis |
Timeline
- Start date
- 2021-04-01
- Primary completion
- 2025-03-30
- Completion
- 2030-03-30
- First posted
- 2022-01-11
- Last updated
- 2022-01-11
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT05185245. Inclusion in this directory is not an endorsement.